Medicare Enrolled
Dr. Daniel Rappaport, MD
Internal Medicine · Whitehall, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rappaport from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rappaport?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rappaport
Dr. Daniel Rappaport is an internal medicine specialist in Whitehall, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rappaport performed 3,323 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Rappaport received a total of $4,643 from 39 pharmaceutical and/or device companies across 282 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rappaport is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 5% volume in PA
$4,643 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,323
Medicare services
Top 5% in PA for internal medicine
Not available
Unique patients (not deduplicated)
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,800 | $18 | $47 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
339 | $8 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
307 | $84 | $211 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
150 | $4 | $15 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
107 | $72 | $100 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
107 | $29 | $56 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
104 | $121 | $283 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
102 | $125 | $181 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
60 | $58 | $127 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
46 | $93 | $246 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
32 | $9 | $65 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $65 | $144 |
| Injection, methylprednisolone acetate, 40 mg | 24 | $6 | $16 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
21 | $50 | $161 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
21 | $214 | $406 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
18 | $11 | $76 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
18 | $142 | $289 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
13 | $3 | $10 |
| Nursing facility discharge management, more than 30 minutes This service involves care coordination and management activities performed by a healthcare professional to prepare a patient for discharge from a nursing facility. It requires more than 30 minutes of time spent on these activities. |
13 | $102 | $204 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
12 | $59 | $140 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$4,643
Total received (2018-2024)
Avg $663/year across 7 years
Top 13% in PA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
282
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$493
2023
$640
2022
$425
2021
$927
2020
$433
2019
$917
2018
$808
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$127
Amgen Inc.
$65
Exact Sciences Corporation
$60
Novo Nordisk Inc
$57
Boehringer Ingelheim Pharmaceuticals, Inc.
$37
Radius Health, Inc.
$35
Seqirus USA Inc
$18
ABBVIE INC.
$17
Merck Sharp & Dohme LLC
$17
PFIZER INC.
$16
Lilly USA, LLC
$16
GlaxoSmithKline, LLC.
$15
Almatica Pharma LLC
$14
Top 3 companies account for 51.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$811
AstraZeneca Pharmaceuticals LP
$737
Amgen Inc.
$506
Boehringer Ingelheim Pharmaceuticals, Inc.
$461
Lilly USA, LLC
$331
Amarin Pharma Inc.
$221
Astellas Pharma US Inc
$208
SANOFI-AVENTIS U.S. LLC
$132
Exact Sciences Corporation
$117
Janssen Pharmaceuticals, Inc
$109
GlaxoSmithKline, LLC.
$92
PFIZER INC.
$79
Novartis Pharmaceuticals Corporation
$72
AbbVie Inc.
$67
Radius Health, Inc.
$66
Biohaven Pharmaceuticals, Inc.
$64
ABBVIE INC.
$57
Kowa Pharmaceuticals America, Inc.
$52
Allergan Inc.
$51
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$45
Takeda Pharmaceuticals U.S.A., Inc.
$41
Allergan, Inc.
$40
Bayer HealthCare Pharmaceuticals Inc.
$29
Avanir Pharmaceuticals, Inc.
$29
Merck Sharp & Dohme Corporation
$23
Seqirus USA Inc
$18
Merck Sharp & Dohme LLC
$17
SANOFI PASTEUR INC.
$16
Philips Electronics North America Corporation
$16
Abbott Laboratories
$15
BioDelivery Sciences International, Inc.
$15
Esperion Therapeutics, Inc.
$14
Biohaven Pharmaceutical Holding Company Ltd.
$14
E.R. Squibb & Sons, L.L.C.
$14
Almatica Pharma LLC
$14
IDORSIA PHARMACEUTICALS US INC
$13
Braemar Manufacturing, LLC
$12
Ironwood Pharmaceuticals, Inc
$12
Eisai Inc.
$12
Top 3 companies account for 44.2% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AIRSUPRA · AREXVY · Aimovig · Amitiza · BASAGLAR · BELBUCA · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · Belviq · CHANTIX · Cardiac Monitoring Suite · Cologuard Collection Kit · DUZALLO · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FASENRA · FLUZONE HIGH-DOSE · Fluad · FreeStyle Libre 2 · GARDASIL · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LOREEV XR · Livalo · MOUNJARO · MOVANTIK · MYRBETRIQ · Motegrity · Myrbetriq · NEXLETOL · NUEDEXTA · NURTEC ODT · Otezla · Ozempic · PAXLOVID · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRULICITY · Tresiba · Tymlos · UBRELVY · VESICARE · VIBERZI · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
761
County median income
$77,493
Nearest hospital to ZIP centroid (approximate)
LEHIGH VALLEY HOSPITAL
6.1 mi
6.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rappaport is a mixed practice specialist, with above-average Medicare volume (top 5% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rappaport experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Rappaport performed 1,800 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rappaport receive payments from pharmaceutical companies?
Yes. Dr. Rappaport received a total of $4,643 from 39 companies across 282 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rappaport's costs compare to other internal medicine physicians in Whitehall?
Dr. Rappaport's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rappaport) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Whitehall
Browse internal medicine physicians in Whitehall ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in PA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in PA
Which PA internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology